Pharming (PHAR) Other Non-Current Assets (2019 - 2026)

Pharming (PHAR) has 8 years of Other Non-Current Assets data on file, last reported at $1.2 million in Q2 2026.

• Quarterly Other Non-Current Assets fell 55.06% year-over-year to $1.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 million (down 55.06% YoY) and the FY2025 annual result came in at $1.2 million, down 18.47% from the prior year.
• Other Non-Current Assets advanced to $1.2 million in Q2 2026, from $895000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.7 million in Q2 2025 to a low of $92000.0 in Q4 2023.
• A 5-year average of $1.3 million and a median of $1.3 million in 2023 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets plunged 91.63% — and 2024, when it soared 1535.87%.
• Tracing PHAR's Other Non-Current Assets over 5 years: stood at $1.1 million in 2022, then sank by 91.63% to $92000.0 in 2023, then soared by 1535.87% to $1.5 million in 2024, then decreased by 18.47% to $1.2 million in 2025, then dropped by 0.16% to $1.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.2 million (Q2 2026), $895000.0 (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.